77.51M
Market cap
Current P/E
Forward P/E

About

Health care
Sector
Medical - Diagnostics & Research
Industry

23andMe Holding Co. operates as a consumer genetics testing company. It operates through two segments, Consumer & Research Services and Therapeutics. The Consumer & Research Services segment provides a suite of genetic reports, including information on customers' genetic ancestral origins, personal genetic health risks, and chances of passing on certain rare carrier conditions to their children, as well as reports on how genetics can impact responses to medications based on genetic testing of a saliva sample through its spit kit.

Similar securities

Based on sector and market capitalization

Report issue